Skip to content

Yoga therapy for management of polycystic ovarian syndrome in 19-45 year females.

Efficacy of yoga therapy vs. lifestyle modification for management of polycystic ovarian syndrome in 19-45 year females: a randomized controlled trial.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/04/024602
Enrollment
100
Registered
2020-04-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

Intervention1: Yoga therapy: Yoga therapy session of: 1) 36 minutes 2) total period 12 weeks 3) physical postures (asana) 4) breathing techniques (pranayama) 5) relaxation techniques 6) guided medit

Sponsors

AIIMS Rishikesh
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) patients satisfying Rotterdam criterion for PCOS which is based on any two of the following features: a) oligomenorrhea/amenorrhea, b) clinical and/or biochemical hyperandrogenism, c) polycystic ovaries on ultrasound 2) patients requiring only first line treatment i.e. lifestyle modification

Exclusion criteria

Exclusion criteria: 1) patients requiring infertility treatment 2) patients suffering from type II diabetes / hypothyroidism / hyperprolactinemia / non-classic congenital adrenal hyperplasia / hypogonadotropic hypogonadism / Cushingâ??s disease / androgen producing tumours / any other severe illness or co-morbid status 3) use of oral contraceptives / hormone treatment / insulin-sensitizing agents within previous six weeks 4) pregnancy 5) current or past smoker

Design outcomes

Primary

MeasureTime frame
Reduction in menstrual cycle length to less than 35 daysTimepoint: Baseline, 3 months and 6 months

Secondary

MeasureTime frame
1) reduction in testosterone level 2) reduction in hirsutism (mFG scale) 3) reduction in BMI (Body Mass Index) 4) reduction in waist/hip ratio 5) improvement in lipid profile 6) reduction in fasting serum insulin levels 7) reduction in plasma glucose levels 8) reduction in anxiety and depression (GAD7 scale)Timepoint: Baseline, 3 months and 6 months

Countries

India

Contacts

Public ContactMs Anita Verma

AIIMS Rishikesh

anita.v.9@gmail.com9997454915

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026